KD951 : Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases/95 cores,replaced by KD951a
  • $1,195.00
Microarray Panel Renal carcinoma tissue microarray, duplicated cores, 31 cancer and 8 of which has matched normal adjacent tissue and 8 of matched metastasis and 1 unmatched metastasis, with follow-up data
Cores 95
Biomax.com Tissue Array KD951
Cases 32
Layout SBC
Row number 8
Column number 12
Core Diameter (mm) 1.5
Thickness (µm) 5
IHC1 Anti-Actin confirmed
Tissue Array Type FFPE
Species Human
Applications Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Mouseover and click individual cores to view high resolution images.
Slide Label: US Biomax, Inc. Tissue Array
123456789101112
AKidKidKidKidKidKidKidKidKidKidKidKid
BKidKidKidKidKidKidKidKidKidKidKidKid
CKidKidKidKidKidKidKidKidKidKidKidKid
DKidKidKidKidKidKidKidKidKidKidKidKid
EKidKidKidKidKidKidKidKidKidKidKidKid
FKidKidAdrAdrBonBonLymLymLunLunThrThr
GLymLymIntIntSplSplAdrAdrKidKidKidKid
HKidKidKidKidKidKidKidKidKidKidKidKid
Legend: Adr - Adrenal gland, Bon - Bone, Int - Intestine, Kid - Kidney, Lun - Lung, Lym - Lymph node, Spl - Spleen, Thr - Thyroid

Specification Sheet (Sortable), tissue IDs are available in exported Excel files.

No.Size(cm)Capsule involveVein involveOtherMonths*Follow-up monthsFollow-up resultCause of deathRemark
1 8.5 - - - . 101 alive . .
2 8.5 - - - . 101 alive . .
3 12 + - - . . . . .
4 12 + - - . . . . .
5 6 + - - . . . . .
6 6 + - - . . . . .
7 10 + + - . . . . .
8 10 + + - . . . . .
9 7.5 + + +* . . . . .
10 7.5 + + +* . . . . .
11 9 + + - . 65 dead cancer .
12 9 + + - . 65 dead cancer .
13 7.5 + - - . 116 alive . .
14 7.5 + - - . 116 alive . .
15 3.5 - - - . 113 alive . .
16 3.5 - - - . 113 alive . .
17 4 - - - . 112 alive . .
18 4 - - - . 112 alive . .
19 6 + + - . 112 alive . .
20 6 + + - . 112 alive . .
21 4 + - - . 110 alive . .
22 4 + - - . 110 alive . .
23 5.5 - - +* . 110 alive . .
24 5.5 - - +* . 110 alive . .
25 6 + - - . 107 alive . .
26 6 + - - . 107 alive . .
27 5.4 + - - . 59 dead chronic renal failure .
28 5.4 + - - . 59 dead chronic renal failure .
29 17 - + - . 90 dead cancer .
30 17 - + - . 90 dead cancer .
31 6.5 - - - . 105 alive . .
32 6.5 - - - . 105 alive . .
33 11 - - +* . 103 alive . .
34 11 - - +* . 103 alive . .
35 4 + + - . 31 dead cancer .
36 4 + + - . 31 dead cancer .
37 6 - - - . 100 alive . .
38 6 - - - . 100 alive . .
39 4.5 + - - . 99 alive . .
40 4.5 + - - . 99 alive . .
41 2.5 + - - . 18 dead cancer .
42 2.5 + - - . 18 dead cancer .
43 3 + - - . 97 alive . .
44 3 + - - . 97 alive . .
45 13 + + - . . . . .
46 13 + + - . . . . .
47 7 + - - . 43 dead cancer .
48 7 + - - . 43 dead cancer .
49 7.5 + - - . 85 dead cancer .
50 7.5 + - - . 85 dead cancer .
51 10 + - - . 101 alive . .
52 10 + - - . 101 alive . .
53 7 + + - . 105 alive . .
54 7 + + - . 105 alive . .
55 10.5 - - - . 15 dead cancer .
56 10.5 - - - . 15 dead cancer .
57 7 - - - . 100 alive . .
58 7 - - - . 100 alive . .
59 10 - + +* . 4 dead cancer .
60 10 - + +* . 4 dead cancer .
61 12 + - + . . . . .
62 12 + - + . . . . .
63 . . . . 0 . . . .
64 . . . . 0 . . . .
65 . . . . 11 . . . .
66 . . . . 11 . . . .
67 . . . . 0 . . . .
68 . . . . 0 . . . .
69 . . . . 2 . . . .
70 . . . . 2 . . . .
71 . . . . 79 . . . .
72 . . . . 79 . . . .
73 . . . . 7 . . . .
74 . . . . 7 . . . .
75 . . . . 16 . . . .
76 . . . . 16 . . . .
77 . . . . 0 . . . .
78 . . . . 0 . . . .
79 . . . . . . . . .
80 . . . . . . . . .
81 . . . . . . . . .
82 . . . . . . . . .
83 . . . . . . . . .
84 . . . . . . . . .
85 . . . . . . . . .
86 . . . . . . . . .
87 . . . . . . . . .
88 . . . . . . . . .
89 . . . . . . . . .
90 . . . . . . . . .
91 . . . . . . . . .
92 . . . . . . . . .
93 . . . . . . . . .
94 . . . . . . . . .
95 . . . . . . . . .
96 . . . . . . . . .

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
 

Write a review

Please login or register to review

Tags: Duplicate cores per case, Metastasis, With normal control, With adjacent normal, With normal control (), Stage (TNM), Survival data